QIAGEN N.V. (QGEN)

NL0015001WM6 - Common Stock

42.58  -0.4 (-0.93%)

After market: 42.58 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

QIAGEN N.V.

NYSE:QGEN (5/6/2024, 7:23:29 PM)

After market: 42.58 0 (0%)

42.58

-0.4 (-0.93%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap9.43B
Shares
PE20.08
Fwd PE19.74
Dividend Yield3.1%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

QGEN Daily chart

Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 6,178 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Company Info

QIAGEN N.V.

Hulsterweg 82

Venlo LIMBURG 5912

P: 31773556600

CEO: Thierry Bernard

Employees: 6178

Website: https://www.qiagen.com/

QGEN News

News Image15 hours ago - Market News VideoQiagen Moves Up In Market Cap Rank, Passing Boston Properties
News Image5 days ago - QIAGEN N.V.QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications

QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical...

News Image5 days ago - QIAGEN N.V.QIAGEN verbessert Bioinformatik-Workflows mit neuer Sekundäranalyse-Lösung für Onkologie und Erbkrankheiten

QCI Secondary Analysis ist eine direkt in QCI Interpret integrierte, Cloud-basierte Software und ermöglicht durchsatzstarke Sekundäranalyse von klinischen...

News Image7 days ago - BusinessInsiderQGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Qiagen (NYSE:QGEN) just reported results for the first quarter of 2024.Qiagen r...

News Image7 days ago - InvestorPlaceQGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024

QGEN stock results show that Qiagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

News Image8 days ago - QIAGEN N.V.QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance

Q1 2024: Net sales of $459 million (-5% actual rates, -5% constant exchange rates, CER); diluted EPS of $0.36 and adjusted diluted EPS of $0.46 // Net...

QGEN Twits

Here you can normally see the latest stock twits on QGEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example